Antibiotic prophylaxis for percutaneous endoscopic gastrostomy for non-malignant conditions: A double-blind prospective randomized controlled trial

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 6, 2005, Pages 565-570

  Saadeddin, A ^a   Freshwater, D A ^a   Fisher, N C ^a   Jones, B J M ^a  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; PLACEBO;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPIRATION PNEUMONIA; BETA HEMOLYTIC STREPTOCOCCUS; CLINICAL TRIAL; COLIFORM BACTERIUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; SUDDEN DEATH; TREATMENT OUTCOME; WOUND INFECTION;

AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFOTAXIME; DOUBLE-BLIND METHOD; FEMALE; GASTROSCOPY; GASTROSTOMY; HUMANS; INTUBATION, GASTROINTESTINAL; MALE; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION;

EID: 25444476094     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02578.x     Document Type: Article

References (32)

1. Elia M, Russell C, Stratton R, et al. Trends in Artificial Nutrition Support in the UK during 1996-2000. A report by the British Artificial Nutrition Survey (BANS). Maidenhead: Sovereign/BAPEN, 2001.
2. Moran BJ, Taylor MB, Johnson CD. Percutaneous endoscopic gastrostomy. Br J Surg 1990; 77: 858-62.
3. Lockett MA, Templeton ML, Byrne TK, Norcross ED. Percutaneous endoscopic gastrostomy complications in a tertiary-care center. Am Surg 2002; 68: 117-20.
4. Tan W, Rajnakova A, Kum CK, Alponat A, Goh PM. Evaluation of percutaneous endoscopic gastrostomy in a university hospital. Hepatogastroenterology 1998; 45: 2060-3.
5. Norrie MW, Lane MR. Percutaneous endoscopic gastronomy feeding tubes: a retrospective review at Auckland Hospital 1993-4. N Z Med J 1996; 109: 299-301.
6. Ganga UR, Ryan JJ, Schafer LW. Indications, complications, and long-term results of percutaneous endoscopic gastrostomy: a retrospective study. S D J Med 1994; 47: 149-52.
7. Preclik G, Grune S, Leser HG, et al. Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ 1999; 319: 881-4.
8. Bramble MG. Antibiotic Prophylaxis in Gastrointestinal Endoscopy. London: British Society of Gastroenterology, 2001.
9. Sturgis TM, Yancy W, Cole JC, Proctor DD, Minhas BS, Marcuard SP. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1996; 91: 2301-4.
10. Jonas SK, Neimark S, Panwalker AP. Effect of antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1985; 80: 438-41.
11. Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med 1987; 107: 824-8.
12. Gossner L, Keymling J, Hahn EG, Ell C. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial. Endoscopy 1999; 31: 119-24.
13. Dormann AJ, Wigginghaus B, Risius H, et al. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG) - results from a prospective randomized multicenter trial. Z Gastroenterol 2000; 38: 229-34.
14. Dormann AJ. Antibiotic prophylaxis after percutaneous endoscopic gastrotomy insertion. Long acting antibiotic is superior in reducing systemic complication. BMJ 2000; 320: 871-2.
15. Ahmad I, Mouncher A, Abdoolah A, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy - a prospective, randomised, double-blind trial. Aliment Pharmacol Ther 2003; 18: 209-15.
16. Panigrahi H, Shreeve DR, Tan WC, Prudham R, Kaufman R. Role of antibiotic prophylaxis for wound infection in percutaneous endoscopic gastrostomy (PEG): result of a prospective double-blind randomized trial. J Hosp Infect 2002; 50: 312-5.
17. Skelly RH, Kupfer RM, Metcalfe ME, et al. Percutaneous endoscopic gastrostomy (PEG): change in practice since 1988. Clin Nutr 2002; 21: 389-94.
18. Laasch HU, Wilbraham L, Bullen K, et al. Gastrostomy insertion: comparing the options - PEG, RIG or PIG? Clin Radiol 2003; 58: 398-405.
19. Mohammed I, Jones BJ. Antibiotic prophylaxis after percutaneous endoscopic gastrotomy insertion. Widespread routine use of prophylactic antibiotics might predispose to increased risk of resistant organisms. BMJ 2000; 320: 870-1.
20. Haahr M. Web interface to the true random numbers. Available from: URL: http://www.random.org/sform.html.
21. Mandal A, Steel A, Davidson AR, Ashby C. Day-case percutaneous endoscopic gastrostomy: a viable proposition? Postgrad Med J 2000; 76: 157-9.
22. Aschl G, Kirchgatterer A, Allinger S, et al. Indications and complications of percutaneous endoscopic gastrostomy. Wien Klin Wochenschr 2003; 115: 115-20.
23. Taylor CA, Larson DE, Ballard DJ, et al. Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc 1992; 67: 1042-9.
24. Rey JR, Axon A, Budzynska A, Kruse A, Nowak A. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) antibiotic prophylaxis for gastrointestinal endoscopy. European Society of Gastrointestinal Endoscopy. Endoscopy 1998; 30: 318-24.
25. Greff M. Guidelines of the French Society of Digestive Endoscopy (SPED): endoscopic gastrostomy. Endoscopy 1999; 31: 207-8.
26. Hirota WK, Petersen K, Baron TH, et al. Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2003; 58: 475-82.
27. Reacher MH, Shah A, Livermore DM, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000; 320: 213-6.
28. Chaudhary KA, Smith OJ, Cuddy PG, Clarkston WK. PEG site infections: the emergence of methicillin resistant Staphylococcus aureus as a major pathogen. Am J Gastroenterol 2002; 97: 1713-6.
29. Ogundipe OA, Kar-Purkayastha S. An audit of antibiotics usage and their effect on MRSA infection or colonisation following percutaneous endoscopic gastrostomy in a district general hospital. Int J Clin Pract 2004; 58: 632-4.
30. Hull M, Beane A, Bowen J, Settle C. Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites. Aliment Pharmacol Ther 2001; 15: 1883-8.
31. Cameron EAB, McGovern J, Hindle L, Miller C, Fellows IW. Percutaneous endoscopic gastrostomy insertion: can current antibiotic prophylaxis guidelines be effective. Gut 2004; 53(136 Suppl. III): A36.
32. Rao GG, Osman M, Johnson L, Ramsey D, Jones S, Fidler H. Prevention of percutaneous endoscopic gastrostomy site infections caused by methicillin-resistant Staphylococcus aureus. J Hosp Infect 2004; 58: 81-3.